Ims 2025 Myeloma Definition. The international myeloma society and paula and rodger riney foundation are proud to announce the fifth annual “ims translational research award” funding grants focused on. The new consensus, developed through an ims workshop, now considers additional markers like tp53 mutation and a combination of other cytogenetic factors,.
The diagnosis requires ≥10% clonal bone marrow plasma cells or a biopsy proven plasmacytoma plus evidence of one or more multiple myeloma defining events (mde): Several cytogenetic abnormalities such as t(4;14),.